Check back in a few minutes

Server Maintenance

Your server is going through a few minutes of routine maintenance. Please don't touch your browser for a few minutes.

What do I do?

  • If you were posting a comment or making a post on your blog then do not press BACK on your browser. Wait 5 minutes and press the refresh icon on your browser. Your comment or post will be sent as normal.
  • If you are browsing a blog here just wait a few moments and hit refresh. The page you were expecting will appear.

Leukemia: Why Gleevec Got Approved

When officials at the FDA take just 2 1/2 months to approve a new cancer treatment, you know it's got to be some kind of breakthrough. And indeed the drug called Gleevec, which was given the go-ahead last week in record time, has produced dramatic results in patients with a rare malignancy called chronic myeloid leukemia. It's too early to say just how good Gleevec is. But the drug's success so far makes one thing clear. When designing a safe, effective treatment for a particular cancer, it pays to learn as much as possible about its underlying molecular biology.

Chronic myeloid...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!